In fact, in patients with liver cirrhosis, impaired hepatic function seems to override the effect of PCSK9 on cholesterol metabolism, as demonstrated by the loss of the correlation between cholesterol and PCSK9. The gene discussed is PCSK9; the disease is cirrhosis of liver.